フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3...
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China Mithra and Gedeon Richter...
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States Mithra receives guidance...
Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam...
Mithra’s NEXTSTELLIS® granted additional patent in...
Mithra releases invitation to its extraordinary securities holders’ meeting Mithra releases invitation to its extraordinary...
Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada Mithra and...
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Mithra to receive EUR 2.5...
Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting...
Shareholder Letter Dear Shareholders, We write to you today with a deep sense of responsibility and transparency, driven by our...
Mithra announces update to the agenda of its upcoming special general shareholders’ meeting Liege, Belgium, 11 October 2023 –...
Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress Mithra to hold...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約